eli lilly phase 3 trial retatrutide said Thursday its experimental obesity drug delivered up to 28.3 percent body-weight reduction over 80 weeks in the pivotal TRIUMPH-1 trial, a result nearing the weight-loss range Lilly's triple agonist achieves 16.8%

The strongest results came with higher doses taken consistently

Research from obesity pharmacotherapy trials consistently shows that higher protein intake (targeting 0.8-1.0 grams per pound of goal body weight daily) significantly improves lean mass retention during rapid weight loss

Missed dose If you realize within a day or two of your scheduled weekly injection, you may be able to take it-but always follow your specific medication guide and provider instructions

To do this, they used a group of tools known as epigenetic clocks, which estimate how quickly the body is aging by analyzing DNA methylation patterns

Week 3 I was cleared to up the dose a bit so I did

doi: 10.1038/s41366-018-0303-y 135 HajnalAKovacsPAhmedTMeirellesKLynchCJCooneyRN